MedTrace Logo

Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

NCT00003793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2014-08-05

No results posted yet for this study

Summary

RATIONALE: Determination of genetic markers for soft tissue sarcoma or rhabdomyosarcoma may help doctors identify patients who are at risk for therapy-related leukemia.

PURPOSE: Clinical trial to study genetic testing of children with soft tissue sarcoma or rhabdomyosarcoma to identify children who are at risk of developing leukemia from the chemotherapy used to treat sarcoma.

Conditions

Interventions

GENETIC

clonality analysis

GENETIC

microsatellite instability analysis

GENETIC

mutation analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Stella M. Davies, MBBS, PhD · Children's Hospital Medical Center, Cincinnati

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-12-31
Primary Completion
2005-12-31
Completion
2007-03-31

Countries

  • United States
  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003793 on ClinicalTrials.gov